Dyne Therapeutics, Inc. (DYN)
19.47
+1.03
(+5.59%)
USD |
NASDAQ |
Dec 10, 13:11
Dyne Therapeutics Total Assets (Quarterly): 867.06M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Avidity Biosciences, Inc. | 2.134B |
| CEL-SCI Corp. | 20.34M |
| AIM ImmunoTech, Inc. | 5.494M |
| IGC Pharma, Inc. | 9.743M |
| NovaBay Pharmaceuticals, Inc. | 3.487M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 175.28M |
| Shareholders Equity (Quarterly) | 691.78M |
| Debt to Equity Ratio | 0.1741 |
| Current Ratio | 13.47 |
| Net Debt Paydown Yield | -1.05% |